Diane Greeley

Title: The Innovative Contributions of Diane Greeley

Introduction

Diane Greeley is a prominent inventor based in Watchung, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative combinations for treating proliferative diseases. With a total of 2 patents, her work has the potential to impact the medical community significantly.

Latest Patents

Diane Greeley's latest patents include groundbreaking inventions. One patent focuses on combinations comprising epothilones and pharmaceutical uses thereof. This invention relates to a combination that includes a bisphosphonate, a platinum compound, or a vasculostatic compound alongside an epothilone derivative. The active ingredients are designed for simultaneous, separate, or sequential use, particularly for delaying the progression or treating solid tumor diseases. Another patent involves combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative. This innovation allows for the co-administration of epothilone derivatives with antidiarrheal agents, such as DPP-IV inhibitors, in the treatment of proliferative diseases.

Career Highlights

Diane Greeley is currently associated with Novartis AG, a leading global healthcare company. Her work at Novartis has allowed her to focus on developing innovative pharmaceutical solutions that address critical health challenges.

Collaborations

Diane has collaborated with notable colleagues, including John David Rothermel and TianLing Chen. These collaborations have further enhanced her research and development efforts in the pharmaceutical field.

Conclusion

Diane Greeley's contributions to the field of pharmaceuticals through her innovative patents demonstrate her commitment to advancing medical science. Her work continues to pave the way for new treatments that can significantly improve patient outcomes.